Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CytomX Therapeutics (CTMX) Cash & Current Investments (2016 - 2025)

CytomX Therapeutics' Cash & Current Investments history spans 12 years, with the latest figure at $137.1 million for Q4 2025.

  • For Q4 2025, Cash & Current Investments rose 36.2% year-over-year to $137.1 million; the TTM value through Dec 2025 reached $137.1 million, up 36.2%, while the annual FY2025 figure was $137.1 million, 36.2% up from the prior year.
  • Cash & Current Investments reached $137.1 million in Q4 2025 per CTMX's latest filing, down from $143.6 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $393.8 million in Q1 2021 to a low of $79.9 million in Q1 2025.
  • Average Cash & Current Investments over 5 years is $192.9 million, with a median of $187.3 million recorded in 2022.
  • Peak YoY movement for Cash & Current Investments: skyrocketed 58.84% in 2021, then tumbled 46.84% in 2025.
  • A 5-year view of Cash & Current Investments shows it stood at $305.2 million in 2021, then tumbled by 36.56% to $193.6 million in 2022, then fell by 9.88% to $174.5 million in 2023, then crashed by 42.34% to $100.6 million in 2024, then skyrocketed by 36.2% to $137.1 million in 2025.
  • Per Business Quant, the three most recent readings for CTMX's Cash & Current Investments are $137.1 million (Q4 2025), $143.6 million (Q3 2025), and $158.1 million (Q2 2025).